Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Neil Easton"'
Publikováno v:
Day 1 Mon, April 16, 2018.
In common with every company involved in the global upstream oil and gas industry, oilfield service companies rely to a large extent on front-line operators monitoring key operational parameters in real time, and being willing and able to intervene i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a33a2257db84cfe324fcc4fad9d6b84
https://doi.org/10.2118/190670-ms
https://doi.org/10.2118/190670-ms
Publikováno v:
Neuropharmacology. 57:653-664
Methylphenidate (Ritalin®) is a selective dopamine reuptake inhibitor and an effective treatment for attention deficit hyperactivity disorder (ADHD) however the anatomical foci and neuronal circuits involved in these therapeutic benefits are unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7c7169779ba2647aa48d47e840cef3
https://doi.org/10.1016/j.neuropharm.2009.08.018
https://doi.org/10.1016/j.neuropharm.2009.08.018
Publikováno v:
Psychopharmacology. 193:11-30
The D - and L-amphetamine sulphate isomers are used in the formulation of Adderall XR(R), which is effective in the treatment of attention-deficit hyperactivity disorder (ADHD). The effects of these isomers on brain activity has not been examined usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daebaa30240ce65eacbc073c85f2f82e
https://doi.org/10.1007/s00213-007-0756-5
https://doi.org/10.1007/s00213-007-0756-5
Publikováno v:
Neuropharmacology. 52:812-826
Atomoxetine is a selective noradrenaline reuptake inhibitor used in the treatment of attention deficit hyperactivity disorder (ADHD) which has not yet been assessed using pharmacological neuroimaging for its effects on rat brain activity. The pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db9789ae015d0f8fe68552ab016e815c
https://doi.org/10.1016/j.neuropharm.2006.09.024
https://doi.org/10.1016/j.neuropharm.2006.09.024
Publikováno v:
Neuropharmacology. 52:405-414
D- and L-amphetamine sulphate isomers, methylphenidate and atomoxetine, are effective treatments for attention-deficit hyperactivity disorder (ADHD). This study provides a detailed comparison of their effects on the synaptosomal and vesicular accumul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d518249e24711c233fdcf83c46b33f5
https://doi.org/10.1016/j.neuropharm.2006.07.035
https://doi.org/10.1016/j.neuropharm.2006.07.035
Publikováno v:
Brain Research. 987:144-154
Administration of 3,4-methylenedioxymethamphetamine (MDMA) or 3,4-methylenedioxyamphetamine (MDA) to rats produces serotonergic nerve terminal degeneration. However, they are not neurotoxic when injected directly into the brain, suggesting the requir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9633ff381ee577ac79b280cf584a2378
https://doi.org/10.1016/s0006-8993(03)03319-5
https://doi.org/10.1016/s0006-8993(03)03319-5
Publikováno v:
Psychopharmacology. 189(3)
Guanfacine (an alpha-2A adrenoreceptor agonist) is a drug of benefit in the treatment of attention deficit hyperactivity disorder (ADHD) (Taylor FB, Russo J, J Clin Psychopharmacol 21:223–228, 2001). Assessment of this drug using neuroimaging will
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d0e928628d4165d0cd620d784f8b19
https://pubmed.ncbi.nlm.nih.gov/17016709
https://pubmed.ncbi.nlm.nih.gov/17016709